Skip to main content
Clinical Trials/NCT04058912
NCT04058912UnknownNot Applicable

RELATIONSHIP OF LOW-OVER RESERVE WITH PTEN-AKT-FOXO3 GENE EXPRESSION IN THE PRESENCE OF ENDOMETRIOMAS

Uludag University1 site in 1 country60 target enrollmentStarted: May 27, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
PTEN AKT FOXO3 gene expression

Study Overview

Brief Summary

In this study, we aimed to investigate the relationship between PTEN-AKT-FOXO3 gene expression and decrease in ovarian reserve in the presence of endometrioma and other benign ovarian pathologies.

Detailed Description

It is known that the presence of endometrioma negatively affects ovarian reserve. The development of endometriosis and the effect of the presence of endometrioma on ovarian reserve due to decreased PTEN expression are considered. This study was designed to compare ovarian PTEN-AKT-FOXO3 gene expression and ovarian reserve in patients with underwent surgery caused by endometrioma and those who had ovarian pathology due to other benign causes and PTEN-AKT-FOXO3 gene expression level will be evaluated by RT-PCR analysis.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •To be in the range of 18-40 years 2) Patients with an operation indication with >=5 cm endometrioma 3) Patients with operation plan due to non-endometrioma ovarian pathologies

Exclusion Criteria

  • •Patients over the age of 40 2)Patients with suspected malignancy 3)Follow-up patients without indications for operation

Outcomes

Primary Outcomes

PTEN AKT FOXO3 gene expression

Time Frame: 30 minutes

In the patient and patient control groups, 0.5 mm tissue strip will be removed for pathology from the cyst wall removed during surgery. and tissue samples will be stored in phosphate buffered saline at -80 C and PTEN-AKT-FOXO3 gene expression level will be evaluated by RT-PCR analysis.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Uludag University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

GÜRKAN UNCU,PROF. MD

: Principal Investigator. Professor, Obstetrician and Gynecologist

Uludag University

Study Sites (1)

Loading locations...

Similar Trials